Mark W. Bina quoted in article "Proposed Theranos CEO Ban Ups Ante For Lab Testing Cos."
Below is an excerpt:
"I've seen several of these letters before, but there's no question that CMS is really throwing the book at Theranos here by seeming to maximize every remedy at their disposal," Mark Bina of Quarles & Brady LLP said. "But I think CMS takes very seriously its charge to protect taxpayer money and has an intense focus on startups and newer technologies and wants to take a wait-and-see approach before really getting behind them."